# OnCo record pomegranate-extract (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/pomegranate-extract/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "pomegranate-extract" ;
  schema:name "Pomegranate juice and extract"@en ;
  schema:alternateName "Punica granatum"@en, "Pomegranate juice"@en, "POMx"@en ;
  schema:description "Pomegranate juice became popular among men with prostate cancer after early studies suggested it slowed the rise of prostate-specific antigen. Later placebo-controlled trials were conflicting, and in advanced prostate cancer it did not lower the marker more than placebo. It is generally safe, apart from sugar content and a possible interaction with statins and warfarin."@en ;
  schema:url <https://onco.cc/technologies/pomegranate-extract/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.mskcc.org/cancer-care/integrative-medicine/herbs/pomegranate> ;
  onco:status "phase-2" ;
  onco:tag "complementary", "supportive-care", "evidence:insufficient" ;
  onco:related <https://onco.cc/technologies/saw-palmetto/>, <https://onco.cc/technologies/flaxseed-supplements/> ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:sections <https://onco.cc/fronts/supportive-care/>, <https://onco.cc/fronts/nutrition-lifestyle/> ;
  onco:technologies <https://onco.cc/technologies/integrative-oncology/>, <https://onco.cc/technologies/dietary-supplements-treatment-interactions/>, <https://onco.cc/technologies/curcumin-turmeric/>, <https://onco.cc/technologies/green-tea-egcg/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-misinformation/> .